The Outcome of Patients Treated with Sunitinib Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer-Reference-Cited by-同舟云学术

The Outcome of Patients Treated with Sunitinib Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer

Published:2011-09 Issue:3 Volume:60 Page:448-454
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Powles Thomas,Blank Christian,Chowdhury Simon,Horenblas Simon,Peters John,Shamash Jonathan,Sarwar Naveed,Boleti Ekaterini,Sahdev Anju,O'Brien Tim,Berney Dan,Beltran Luis,Nathan Paul,Haanen John,Bex Axel

Publisher

Elsevier BV

Subject

Urology

Reference20 articles.

1. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2009

2. Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial;Gore;Lancet Oncol,2009

3. Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials;Bex;Eur Urol,2010

4. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer;Flanigan;N Engl J Med,2001

5. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial;Mickisch;Lancet,2001

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytoreductive nephrectomy in metastatic renal cell carcinoma;Cochrane Database of Systematic Reviews;2024-06-07

2. Impact of Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study;Diseases;2024-06-04

3. Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2023-12

4. Current status of nephrectomy in the treatment of metastatic renal cell carcinoma;Onkologie;2023-10-05

5. Role of Surgery in Metastatic Renal Cell Carcinoma;Hematology/Oncology Clinics of North America;2023-10